These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 9161784

  • 21. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T, Sriswasdi C, Mongkonsritragoon W, Leelasiri A, Prayoonwiwat W.
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [Abstract] [Full Text] [Related]

  • 22. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S, Chareoniam V, Isariyodom P, Sungsab D.
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [Abstract] [Full Text] [Related]

  • 23. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ.
    Cancer; 2003 May 01; 97(9):2290-300. PubMed ID: 12712486
    [Abstract] [Full Text] [Related]

  • 24. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G, Krzakowski M, Pawinski A, Lasota W, Rogowski W, Skoneczna I.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [Abstract] [Full Text] [Related]

  • 25. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
    Markman M, Sheidler V, Ettinger DS, Quaskey SA, Mellits ED.
    N Engl J Med; 1984 Aug 30; 311(9):549-52. PubMed ID: 6379459
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG, Berglind AM, Andersson H, Boman K, Högberg T, Hallgren M, Schmidt M.
    Cancer; 1998 Sep 01; 83(5):1022-32. PubMed ID: 9731907
    [Abstract] [Full Text] [Related]

  • 28. [Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
    Lehoczky O, Bagaméri A, Sárosi Z, Kulcsár T, Pulay T.
    Orv Hetil; 2001 Aug 05; 142(31):1681-4. PubMed ID: 11556262
    [Abstract] [Full Text] [Related]

  • 29. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May 05; 8(3):229-32. PubMed ID: 10789965
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis.
    Martoni A, Piana E, Strocchi E, Angelelli B, Guaraldi M, Zamagni C, Camaggi CM, Pannuti F.
    Anticancer Res; 1998 May 05; 18(4B):2799-803. PubMed ID: 9713464
    [Abstract] [Full Text] [Related]

  • 32. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
    Chiersilpa A, Ngow J.
    J Med Assoc Thai; 1999 Sep 05; 82(9):915-21. PubMed ID: 10561949
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA.
    Cancer J Sci Am; 1998 Sep 05; 4(2):72-7. PubMed ID: 9532406
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of droperidol in the prevention of cisplatin-induced delayed emesis: a double-blind, randomised parallel study.
    Minegishi Y, Ohmatsu H, Miyamoto T, Niho S, Goto K, Kubota K, Kakinuma R, Kudoh S, Nishiwaki Y.
    Eur J Cancer; 2004 May 05; 40(8):1188-92. PubMed ID: 15110882
    [Abstract] [Full Text] [Related]

  • 37. An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant.
    Frakes LA, Brehm TL, Kosty MP, Miller WE, McMillan RL, Mason J, Meisenberg BR.
    Bone Marrow Transplant; 1997 Sep 05; 20(6):473-8. PubMed ID: 9313880
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
    Tsavaris N, Kosmas CH, Vadiaka M, Kontos A, Katsorida M, Dimitrakopoulos A, Zerai A, Koufos CH.
    J Exp Clin Cancer Res; 2001 Mar 05; 20(1):29-34. PubMed ID: 11370826
    [Abstract] [Full Text] [Related]

  • 39. [Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
    Ichida T, Isokawa O, Itoh S, Ohta H, Takagi K, Hatakeyama S, Tsuruya T, Doya Y, Nozawa A, Hata K, Hara H, Hirose S, Watanabe T, Asakura H.
    Gan To Kagaku Ryoho; 1998 Oct 05; 25(12):1939-46. PubMed ID: 9797817
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.